Addressing constraints to informal providers' involvement in tuberculosis control: a qualitative study of patent medicine dealers and tuberculosis programme managers

被引:4
作者
Onah, Cosmas Kenan [1 ]
Azuogu, Benedict Ndubueze [1 ,2 ]
Ossai, Edmund Ndudi [1 ,2 ]
Agu, Adaoha Pearl [2 ,3 ]
Azuogu, Victoria Chioma [4 ]
Alobu, Isaac [5 ]
Ogah, Emeka Onwe [6 ]
机构
[1] Alex Ekwueme Fed Univ, Dept Community Med, Teaching Hosp Abakaliki AEFUTHA, PMB 102, Abakaliki, Ebonyi State, Nigeria
[2] Ebonyi State Univ, Coll Hlth Sci, Dept Community Med, Abakaliki, Nigeria
[3] Ebonyi State Univ, African Inst Hlth Policy & Hlth Syst, Abakaliki, Nigeria
[4] AE FUTHA, Dept Nursing Serv, Abakaliki, Ebonyi State, Nigeria
[5] Ebonyi State Minist Hlth, Natl TB, Leprosy & Buruli Ulcer Control Programme, Abakaliki, Nigeria
[6] AE FUTHA, Dept Paediat, Abakaliki, Ebonyi State, Nigeria
关键词
Tuberculosis control; Patent medicine dealers; Chronic cough; Presumptive tuberculosis referral; DOTS; Nigeria; VENDORS;
D O I
10.1186/s41256-021-00227-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background A major constraint to tuberculosis control is low case finding with under-reporting to national authorities. Evidence shows that Patent Medicine Dealers are first port of call for most people with symptoms of tuberculosis, yet there is poor referral of such clients to tuberculosis treatment facilities for further evaluation. This study investigated constraints to involvement of Patent Medicine Dealers in tuberculosis control. Methods This was a cross-sectional qualitative study among Patent Medicine Dealers and Tuberculosis Control Programme Managers in Ebonyi State Nigeria. Sixty-four Patent Medicine Dealers and five Tuberculosis Control Programme Managers were interviewed using Focus Group Discussion and In-Depth Interview respectively. Data was collected with electronic audio-recording device and analyzed using thematic approach. Results There are some knowledge gaps about tuberculosis signs, symptoms, free-treatment policy and mode of operation of care service among Patent Medicine Dealers. Patent Medicine Dealers and Tuberculosis Control Programme Managers are willing to collaborate in tuberculosis control effort but constant demand for incentives by Patent Medicine Dealers and inability of National Tuberculosis Control Programme to keep up with such demands are obvious constraints. Conclusions Knowledge gaps in tuberculosis, its control, constant demand for incentives by Patent Medicine Dealers and inability of National Tuberculosis Control Programme to satisfy such demands are constraints to involvement of Patent Medicine Dealers in tuberculosis control. More robust engagement of Patent Medicine Dealers in tuberculosis control with clear job description through tuberculosis education and provision of incentives to support them are recommended policy approaches to improve linkage of clients to tuberculosis treatment facilities.
引用
收藏
页数:12
相关论文
共 43 条
[1]  
Anderson L, 2016, GLOBAL TUBERCULOSIS
[2]  
Aniebue P., 2009, INT J MED HLTH DEV, V13, P91, DOI 10.4314/jcm.v13i2.10588
[3]  
[Anonymous], Global strategy and targets for tuberculosis prevention, care and control after 2015
[4]  
[Anonymous], 2017, GLOB TUB REP
[5]   Knowledge, Risk Perception and Practices Related to Antibiotic Resistance among Patent Medicine Vendors in Sokoto Metropolis, Nigeria [J].
Awosan, K. J. ;
Ibitoye, P. K. ;
Abubakar, A. K. .
NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2018, 21 (11) :1476-1483
[6]  
Barnes J., 2008, Nigeria Private Sector Health Assessment
[7]   A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria [J].
Beyeler, Naomi ;
Liu, Jenny ;
Sieverding, Maia .
PLOS ONE, 2015, 10 (01)
[8]  
Chadha S, 2017, PUBLIC HEALTH ACTION, V7, P123, DOI 10.5588/pha.16.0080
[9]   World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions [J].
Di Angelantonio, Emanuele ;
Kaptoge, Stephen ;
Pennells, Lisa ;
De Bacquer, Dirk ;
Cooney, Marie Therese ;
Kavousi, Maryam ;
Stevens, Gretchen ;
Riley, Leanne ;
Savin, Stefan ;
Altay, Servet ;
Amouyel, Philippe ;
Assmann, Gerd ;
Bell, Steven ;
Ben-Shlomo, Yoav ;
Berkman, Lisa ;
Beulens, Joline W. ;
Bjorkelund, Cecilia ;
Blaha, Michael J. ;
Blazer, Dan G. ;
Bolton, Thomas ;
Bonita, Ruth ;
Brenner, Beaglehole Hermann ;
Brunner, Eric J. ;
Casiglia, Edoardo ;
Chamnan, Parinya ;
Choi, Yeun-Hyang ;
Chowdhury, Rajiv ;
Coady, Sean ;
Crespo, Carlos J. ;
Cushman, Mary ;
Dagenais, Gilles R. ;
D'Agostino, Ralph B. ;
Daimon, Makoto ;
Davidson, Karina W. ;
Engstrom, Gunnar ;
Fang, Xianghua ;
Ford, Ian ;
Gallacher, John ;
Gansevoort, Ron T. ;
Gaziano, Thomas Andrew ;
Giampaoli, Simona ;
Grandits, Greg ;
Grimsgaard, Sameline ;
Grobbee, Diederick E. ;
Gudnason, Vilmundur ;
Guo, Qi ;
Humphries, Steve ;
Iso, Hiroyasu ;
Jukema, J. Wouter ;
Kauhanen, Jussi .
LANCET GLOBAL HEALTH, 2019, 7 (10) :E1332-E1345
[10]  
Divakaran B, 2011, EPIDEMIOL BIOSTAT PU, V8, P14